Log in to save to my catalogue

The cancer-associated secretory phenotype: a new frontier in targeted therapeutics

The cancer-associated secretory phenotype: a new frontier in targeted therapeutics

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11364386

The cancer-associated secretory phenotype: a new frontier in targeted therapeutics

About this item

Full title

The cancer-associated secretory phenotype: a new frontier in targeted therapeutics

Publisher

United States: American Society for Clinical Investigation

Journal title

The Journal of clinical investigation, 2024-09, Vol.134 (17), p.1-3

Language

English

Formats

Publication information

Publisher

United States: American Society for Clinical Investigation

More information

Scope and Contents

Contents

Tan discusses the cancer-associated secretory phenotypes (CASPs). Somatic mutations activate CASPs by initiating cargo-specific secretory vesicle biogenesis in the Golgi and accelerating anterograde trafficking of secretory vesicles from Golgi to plasma membrane. Embedded within the CASP regulatory network are Golgi-resident protein complexes that...

Alternative Titles

Full title

The cancer-associated secretory phenotype: a new frontier in targeted therapeutics

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11364386

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11364386

Other Identifiers

ISSN

1558-8238,0021-9738

E-ISSN

1558-8238

DOI

10.1172/JCI182652

How to access this item